维普期刊资源整合服务平台（V6.5）

199篇 您的检索式：作者名="URAMOTO H"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR 显示文摘	Uramoto H Uchimni T Izumi H	2007	Anticancer Res2007，27，4：	1
2	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR 显示文摘	Uramoto H Uchiumi T Izumi H	2007	Anticancer Res2007，27，4：	1
3	Expression of se- lected gene for acquired drug resistance to EGFR-TKI in lung ad- 显示文摘	Uramoto H Shimokawa H Hanagiri T	2011	Lung Cancer2011，73，3：	1
4	Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer显示文摘	Hanagiri T Sugio K Uramoto H	2007	Surg Today2007，37，7：	1
5	Altered expression of amylold precursors proteins after traumatic brain injury in rats:in situ hybridization and immunohistochemical study 显示文摘	Masumura M Hata R Uramoto H	2000	J Neurotrauma2000，17，：	1
6	Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma显示文摘	Uramoto H Shimokawa H Hanagiri T	2011	Lung Cancer2011，，03：	1
7	Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer显示文摘	Uramoto H Mitsudomi T	2007	Br J Cancer2007，96，6：	1
8	Transport of phenol from aqueous solution to organic solvent through a microporous membrane made of crosslinkedpoly(4-vinylpyridine)显示文摘	Uramoto H Kawabata N Teramoto M	1991	Journal of Membrane Science1991，62，2：	1
9	Which biomarker predicts benefit from EGFRTKI treatment for patients with lung cancer显示文摘	Uramoto H Mitsudomi T	2007	Br J Cancer2007，96，6：	1
10	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutatin in exon 20 of EGFR 显示文摘	Uramoto H Uchiumi T Izumi H	2007	Anticancer Res2007，27，4：	1
11	TS,DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed显示文摘	Uramoto H Onitsuka T Shimokawa H		0，，：	1
12	Epithelial- esenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma 显示文摘	URAMOTO H IWATA T ONITSUKA T	2010	Anticancer Res2010，30，7：	1
13	Expression of endo- plasmic reticulum molecular chaperone GRP78 in human lung cancer and its clinical significance 显示文摘	Uramoto H Sugio K Oyama T	2005	Lung cancer2005，49，：	1
14	Expression of endo- plasmic reticulum molecular chaperone G RP78 in human lung cancer and its clinical significance显示文摘	URAMOTO H SUGIO K OYAMA T	2005	Lung Cancer2005，49，1：	1
15	Overexpression of MACC1 mRNA in tung adenocarcinoma is associated with postoper- ative recurrence 显示文摘	Shimokawa H Uramoto H Onitsuka T	2011	J Thorac Cardiovasc Surg2011，141，4：	1
16	Chloride channel inhibition prevents ROS dependent apoptosis induced by ischemia-reperfusion in mouse cardiomyocytes 显示文摘	Wang XM Takahashi N Uramoto H	2005	Cell Physiol Biochem2005，16，46：	1
17	Gender difference asapmg- nostie factor in patients undergoing resection of non-small cell lung cancer显示文摘	Hanagirl T Sugio K Uramoto H	2007	Surg Today2007，37，7：	1
18	Molecular diagnosis ofMACC1 status in lung adenocarcinnma by immunohistochemicalanalysis显示文摘	Chundong G Uramoto H Onitsuka T	2011	Anticancer Res2011，31，4：	1
19	Physical interaction of tu-mour suppressor p53/p73 with CCAAT-bindiHg transeription factor 2 (CTF2) and differential regulation of human high-mobility group 19HMGI gene expression 显示文摘	Uramoto H Izumi H Nagatani G	2003	Bioehem J2003，371，2：	1
20	A new mechanism for primary resistance to gefitinib in lung adenocarcinoma:the role of a novel G796A mutation in exon 20 of EGFR显示文摘	Uramoto H Uchiumi T Izumi H	2007	Antieancer Res2007，27，4：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示